Neuroprotective Effect of Oxaloacetate in a Focal Brain Ischemic Model in the Rat

Cellular and Molecular Neurobiology

Volumn 35, Issue 1, 2015, Pages 17-22

  Knapp, L ^a   Gellert L ^a,b   Kocsis, K ^a,b   Kis, Z ^a   Farkas, T ^a   Vecsei L ^b   Toldi, J ^a,b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Fluoro Jade C; Glutamate scavenging; Middle cerebral artery occlusion; Neuroprotection; Oxaloacetate; Somatosensory evoked responses

Indexed keywords

NEUROPROTECTIVE AGENT; OXALOACETIC ACID;

ANIMAL; BRAIN ISCHEMIA; DISEASE MODEL; MALE; PATHOLOGY; RAT; TREATMENT OUTCOME; WISTAR RAT;

ANIMALS; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; MALE; NEUROPROTECTIVE AGENTS; OXALOACETIC ACID; RATS; RATS, WISTAR; TREATMENT OUTCOME;

EID: 84924804751     PISSN: 02724340     EISSN: 15736830     Source Type: Journal    
DOI: 10.1007/s10571-014-0064-7     Document Type: Article

References (27)

1. Beart PM, O’Shea RD (2007) Transporters for L-glutamate: an update on their molecular pharmacology and pathological involvement. Br J Pharmacol 150:5–17
2. Bickel U, Yoshikawa T, Pardridge WM (2001) Delivery of peptides and proteins through the blood-brain barrier. Adv Drug Deliv Rev 46:247–279
3. Boyko M, Stepensky D, Gruenbaum BF, Gruenbaum SE, Melamed I, Ohayon S, Glazer M, Shapira Y, Zlotnik A (2012) Pharmacokinetics of glutamate-oxaloacetate transaminase and glutamate-pyruvate transaminase and their blood glutamate-lowering activity in naive rats. Neurochem Res 37:2198–2205
4. Campos F, Sobrino T, Ramos-Cabrer P, Argibay B, Agulla J, Perez-Mato M, Rodriguez-Gonzalez R, Brea D, Castillo J (2011a) Neuroprotection by glutamate oxaloacetate transaminase in ischemic stroke: an experimental study. J cereb blood flow metab 31:1378–1386
5. Campos F, Sobrino T, Ramos-Cabrer P, Castellanos M, Blanco M, Rodriguez-Yanez M, Serena J, Leira R, Castillo J (2011b) High blood glutamate oxaloacetate transaminase levels are associated with good functional outcome in acute ischemic stroke. J cereb blood flow metab 31:1387–1393
6. Campos F, Sobrino T, Ramos-Cabrer P, Castillo J (2012) Oxaloacetate: a novel neuroprotective for acute ischemic stroke. Int J Biochem Cell Biol 44:262–265
7. Campos F, Sobrino T, Perez-Mato M, Rodriguez-Osorio X, Leira R, Blanco M, Mirelman D, Castillo J (2013) Glutamate oxaloacetate transaminase: a new key in the dysregulation of glutamate in migraine patients. Cephalalgia 33:1148–1154
8. Choi DW (1988) Glutamate neurotoxicity and diseases of the nervous system. Neuron 1:623–634
9. Danbolt NC (2001) Glutamate uptake. Prog Neurobiol 65:1–105
10. Farkas T, Perge J, Kis Z, Wolff JR, Toldi J (2000) Facial nerve injury-induced disinhibition in the primary motor cortices of both hemispheres. Eur J Neurosci 12:2190–2194
11. Ginsberg MD (2008) Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology 55:363–389
12. Gottlieb M, Wang Y, Teichberg VI (2003) Blood-mediated scavenging of cerebrospinal fluid glutamate. J Neurochem 87:119–126
13. Knapp L, Gellert L, Heredi J, Kocsis K, Olah G, Fuzik J, Kis Z, Vecsei L, Toldi J, Farkas T (2013) A simple novel technique to induce short-lasting local brain ischaemia in the rat. Neuropathol Appl Neurobiol. doi:10.1111/12069
14. Marosi M, Fuzik J, Nagy D, Rakos G, Kis Z, Vecsei L, Toldi J, Ruban-Matuzani A, Teichberg VI, Farkas T (2009) Oxaloacetate restores the long-term potentiation impaired in rat hippocampus CA1 region by 2-vessel occlusion. Eur J Pharmacol 604:51–57
15. Nagy D, Marosi M, Kis Z, Farkas T, Rakos G, Vecsei L, Teichberg VI, Toldi J (2009) Oxaloacetate decreases the infarct size and attenuates the reduction in evoked responses after photothrombotic focal ischemia in the rat cortex. Cell Mol Neurobiol 29:827–835
16. Nagy D, Knapp L, Marosi M, Farkas T, Kis Z, Vecsei L, Teichberg VI, Toldi J (2010) Effects of blood glutamate scavenging on cortical evoked potentials. Cell Mol Neurobiol 30:1101–1106
17. O’Kane RL, Martinez-Lopez I, DeJoseph MR, Vina JR, Hawkins RA (1999) Na(+)-dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) of the blood-brain barrier. A mechanism for glutamate removal. J Biol Chem 274:31891–31895
18. Pawlik G, Rackl A, Bing RJ (1981) Quantitative capillary topography and blood flow in the cerebral cortex of cats: an in vivo microscopic study. Brain Res 208:35–58
19. Ruban A, Berkutzki T, Cooper I, Mohar B, Teichberg VI (2012) Blood glutamate scavengers prolong the survival of rats and mice with brain-implanted gliomas. Invest New Drugs 30:2226–2235
20. Teichberg VI (2011) GOT to rid the body of excess glutamate. J Cereb Blood Flow Metab 31:1376–1377
21. Teichberg VI, Cohen-Kashi-Malina K, Cooper I, Zlotnik A (2009) Homeostasis of glutamate in brain fluids: an accelerated brain-to-blood efflux of excess glutamate is produced by blood glutamate scavenging and offers protection from neuropathologies. Neuroscience 158:301–308
22. Toldi J, Rojik I, Feher O (1994) Neonatal monocular enucleation-induced cross-modal effects observed in the cortex of adult rat. Neuroscience 62:105–114
23. Vesce S, Rossi D, Brambilla L, Volterra A (2007) Glutamate release from astrocytes in physiological conditions and in neurodegenerative disorders characterized by neuroinflammation. Int Rev Neurobiol 82:57–71
24. White BC, Sullivan JM, DeGracia DJ, O’Neil BJ, Neumar RW, Grossman LI, Rafols JA, Krause GS (2000) Brain ischemia and reperfusion: molecular mechanisms of neuronal injury. J Neurol Sci 179:1–33
25. Yamamoto HA, Mohanan PV (2003) Effect of alpha-ketoglutarate and oxaloacetate on brain mitochondrial DNA damage and seizures induced by kainic acid in mice. Toxicol Lett 143:115–122
26. Zlotnik A, Gurevich B, Tkachov S, Maoz I, Shapira Y, Teichberg VI (2007) Brain neuroprotection by scavenging blood glutamate. Exp Neurol 203:213–220
27. Zlotnik A, Gurevich B, Cherniavsky E, Tkachov S, Matuzani-Ruban A, Leon A, Shapira Y, Teichberg VI (2008) The contribution of the blood glutamate scavenging activity of pyruvate to its neuroprotective properties in a rat model of closed head injury. Neurochem Res 33:1044–1050